Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent.
about
Oncolytic viral therapy for pancreatic cancer: current research and future directionsOncolytic parvoviruses: from basic virology to clinical applicationsOncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancerActivation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus.TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysisTumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.Oncolytic virotherapy for pancreatic cancer.Parvoviruses-tools to fine-tune anticancer immune responses.Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Oncolytic viruses: a new class of immunotherapy drugs.Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives.Oncolytic viruses-immunotherapeutics on the rise.Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer.The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene.Oncolytic Virotherapy and the Tumor Microenvironment.
P2860
Q27011439-8259E61F-12C8-4943-9459-7B0F342329E1Q28081685-44B99826-B23D-4DF7-B8A2-3DECD273328DQ33579883-980EFFB2-2A67-4E05-AB7D-C4C6F5A50181Q33602876-0B408DBC-5087-4AC0-A562-478647C94A9BQ34059205-9B12548F-F654-4D15-888B-0BCB28DB7108Q34168613-AC433C0D-46B7-412E-90F0-27BAEB2EF3A1Q34576048-FDDFBBEA-1BEA-4C0A-9ABE-F86DEDA51ECCQ34998210-D1F0CF0E-BE50-498E-8DC4-10FB6A0994E3Q35522211-4C781440-9B27-4F4E-91D8-741C14A37061Q35590996-0DAEE6B2-4400-46BD-B3E9-A575B3DE8618Q36456506-6CA2158B-1CF7-47AF-9F32-9CA9BF378AC0Q37263031-E309CE9C-EE1B-4060-ACD8-D4346CBF0100Q37707676-D12B44EC-6EAD-46CA-B04C-DB279C4B3B61Q38577450-84823433-73BE-4A29-AAC1-46FC62FE7637Q38726011-32BE0F5B-A3FD-4CBF-8970-C8231ED15474Q38919107-0B8D772A-62F5-4A52-94B5-1CC269CD6AD2Q39453397-4EEECDBE-1462-442F-BB0D-20410D39681CQ40182196-DFC65C92-FBF7-45C2-B9F4-5079412FCCBCQ41684403-13A4D382-C868-4362-8E24-09AE9542511CQ47100447-935A75C7-E2EE-44DC-9EF1-026679A30DC7Q47547580-C593B64E-ED3C-4494-A102-B3D443F4FB37Q47560690-0AE12861-9A21-4E03-9F7C-7DB9C036BB40
P2860
Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Immune cells participate in th ...... ive infection with this agent.
@en
Immune cells participate in th ...... ive infection with this agent.
@nl
type
label
Immune cells participate in th ...... ive infection with this agent.
@en
Immune cells participate in th ...... ive infection with this agent.
@nl
prefLabel
Immune cells participate in th ...... ive infection with this agent.
@en
Immune cells participate in th ...... ive infection with this agent.
@nl
P2093
P356
P1476
Immune cells participate in th ...... tive infection with this agent
@en
P2093
Celina Cziepluch
Christine S Falk
Jean Rommelaere
Marc Aprahamian
Steffen Schmitt
Svitlana Grekova
Thomas Giese
Zahari Raykov
P304
P356
10.4161/CBT.10.12.13455
P577
2010-12-15T00:00:00Z